Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

TODOS MEDICAL LTD.

(TOMDF)
SummaryQuotesChartsNewsCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
Communiqués de presse de la société TODOS MEDICAL LTD.
07/28TODOS MEDICAL : Retains CRO for COVID-19 Outpatient and Inpatient Phase 2/3 Clin..
AQ
07/27TODOS MEDICAL LTD. : Submission of Matters to a Vote of Security Holders (form 8..
AQ
07/22TODOS MEDICAL : Receives New FDA Certificate of Free Sale for Tollovid Daily&tra..
AQ
07/19Todos Medical to Launch EUA Authorized cPass SARS-CoV-2 Neutralizing Antibody..
GL
07/08TODOS MEDICAL LTD. : Entry into a Material Definitive Agreement, Creation of a D..
AQ
07/07TODOS MEDICAL : Other Events (form 8-K/A)
AQ
07/07Todos Medical Appoints Ilanit Halperin, CPA as Corporate Controller
GL
07/06TODOS MEDICAL : Financial Statements and Exhibits (form 8-K/A)
AQ
06/30TODOS MEDICAL : Other Events, Financial Statements and Exhibits (form 8-K/A)
AQ
06/29Todos Medical Provides End of Second Quarter 2021 Corporate Update
GL
06/28TODOS MEDICAL LTD. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
06/25TODOS MEDICAL LTD. : Changes in Registrant's Certifying Accountant, Financial St..
AQ
06/22TODOS MEDICAL : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND ..
AQ
05/04TODOS MEDICAL LTD. : Other Events (form 8-K)
AQ
05/04TODOS MEDICAL : Receives FDA Certificate of Free Sale for New 5-Day Tollovid Dos..
AQ
04/30TODOS MEDICAL LTD. : Entry into a Material Definitive Agreement, Creation of a D..
AQ
04/23TODOS MEDICAL LTD. : Entry into a Material Definitive Agreement, Completion of A..
AQ
04/22Todos Medical Acquires Provista Diagnostics and Its Proprietary Videssa Breas..
GL
04/21TODOS MEDICAL : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND ..
AQ
04/19Todos Medical Launches Phase 2 Clinical Trial of Its Antiviral 3CL Protease I..
GL
04/14TODOS MEDICAL LTD. : Entry into a Material Definitive Agreement, Creation of a D..
AQ
04/08Todos Medical Receives Notice of Allowance from European Patent Office for Pa..
GL
04/01Todos Medical Completes Automation Equipment Installation and Training for Me..
GL
03/30Todos Medical Enters Into Distribution Partnership with Osang Healthcare for ..
GL
03/29Todos Medical Completes Automation Equipment Installation and Training for a ..
GL
03/23TODOS MEDICAL : Enters Into Automation and Reagent Supply Agreement with MAJL Di..
AQ
03/22TODOS MEDICAL LTD. : Entry into a Material Definitive Agreement (form 8-K)
AQ
03/17Todos Medical Provides Corporate Update
GL
03/12TODOS MEDICAL LTD. : Entry into a Material Definitive Agreement, Creation of a D..
AQ
03/12Todos Medical Announces $7.2M in Sales for February 2021, a 38% Month Over Mo..
GL
03/11TODOS MEDICAL : Applauds Senate and House Passage of the American Recovery Act
AQ
01/26TODOS MEDICAL LTD. : Entry into a Material Definitive Agreement, Creation of a D..
AQ
01/25Todos Medical Announces Strategic Investment by Yozma Group Korea
GL
01/11Todos Medical Announces $4.8 Million in Sales for December 2020, a 50% Month ..
GL
2020Todos Medical Announces Agreement to Supply Natural Wellness Clinics with COV..
GL
2020TODOS MEDICAL : Aditxt Signs Distribution Agreement with Todos Medical Ltd. For ..
AQ
2020Todos Medical Announces Commercial Launch of Proprietary 3CL Protease Inhibit..
GL
2020Todos Medical Announces $3.2 Million in Sales for November 2020, a 269% Incre..
GL
2020TODOS MEDICAL : Provides Strategic Outlook
AQ
2020Todos Medical Provides Strategic Outlook
GL
2020Todos Medical Completes Installation of Lab Automation Equipment at Wisconsin..
GL
2020TODOS MEDICAL : Completes Installation of Lab Automation Equipment at Wisconsin ..
AQ
2020TODOS MEDICAL : Announces Positive In Vitro Data for Tollovid™ Confirming ..
AQ
2020Todos Medical Announces Positive In Vitro Data for Tollovid™ Confirming..
GL
2020TODOS MEDICAL : Announces Positive Initial Clinical Proof-of-Concept Data for a ..
AQ
2020Todos Medical Announces Positive Initial Clinical Proof-of-Concept Data for a..
GL
2020TODOS MEDICAL : Announces Clinical Validation and National CLIA Certification fo..
AQ
2020Todos Medical Announces Clinical Validation and National CLIA Certification f..
GL
2020TODOS MEDICAL : CEO Provides Corporate Update
AQ
2020Todos Medical CEO Provides Corporate Update
GL
2020TODOS MEDICAL : Announces $867,000 in Sales for October 2020
AQ
2020Todos Medical Announces $867,000 in Sales for October 2020
GL
2020TODOS MEDICAL : Trademarks Tollovid for Dietary Supplement NLC-001 and Enters In..
AQ
2020Todos Medical Trademarks Tollovid for Dietary Supplement NLC-001 and Enters I..
GL
2020TODOS MEDICAL : Announces Instrument Validation Complete at MOTO+PARA Mobile Lab
AQ
2020Todos Medical Announces Instrument Validation Complete at MOTO+PARA Mobile La..
GL
2020TODOS MEDICAL : Announces Distribution Agreement with Adial Pharmaceuticals to M..
AQ
2020ADIAL PHARMACEUTICALS : Todos Medical Announces Distribution Agreement with Adia..
AQ
2020Todos Medical Announces Distribution Agreement with Adial Pharmaceuticals to ..
GL
2020TODOS MEDICAL : Receives Notices of Allowance From the European Patent Office Co..
AQ
2020Todos Medical Receives Notices of Allowance From the European Patent Office C..
GL
2020UPDATE :   Todos Medical Reports $2.0 Million in Revenue for the Third Quarter o..
GL
2020TODOS MEDICAL : Reports $2.0 Million in Revenue for the Third Quarter of 2020
AQ
2020Todos Medical Reports $2.0 Million in Revenue for the Third Quarter of 2020
GL
2020TODOS MEDICAL : Enters into Exclusive COVID-19 Testing Supply Agreement with MOT..
AQ
2020Todos Medical Enters into Exclusive COVID-19 Testing Supply Agreement with MO..
GL
2020TODOS MEDICAL : Enters into Exclusive Branding and Distribution Agreement with M..
AQ
2020Todos Medical Enters into Exclusive Branding and Distribution Agreement with ..
GL
2020TODOS MEDICAL : Enters Into COVID-19 PCR Testing Implementation and Equipment Fi..
AQ
2020Todos Medical Enters Into COVID-19 PCR Testing Implementation and Equipment F..
GL
2020TODOS MEDICAL : Expands Existing Contract for COVID-19 PCR Testing Equipment & S..
AQ
2020Todos Medical Expands Existing Contract for COVID-19 PCR Testing Equipment & ..
GL
2020TODOS MEDICAL : CEO Releases Letter to Shareholders
AQ
2020Todos Medical CEO Releases Letter to Shareholders
GL
20203CL Protease Inhibitor NLC-001 Added to COVID-19-focused Joint Venture Betwee..
GL
1  2Next